Cancer Vaccine Cuts the Risk of Melanoma Recurrence, Merck and Moderna Report
Merck and Moderna released detailed results on an experimental vaccine to treat the skin cancer.
https://www.nytimes.com/2026/10/22/well/cancer-vaccine-melanoma-merck-moderna.html